BRPI0410562B8 - proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira - Google Patents
proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeiraInfo
- Publication number
- BRPI0410562B8 BRPI0410562B8 BRPI0410562A BRPI0410562A BRPI0410562B8 BR PI0410562 B8 BRPI0410562 B8 BR PI0410562B8 BR PI0410562 A BRPI0410562 A BR PI0410562A BR PI0410562 A BRPI0410562 A BR PI0410562A BR PI0410562 B8 BRPI0410562 B8 BR PI0410562B8
- Authority
- BR
- Brazil
- Prior art keywords
- plant
- carrier protein
- nucleic acid
- host cell
- production method
- Prior art date
Links
- 102000014914 Carrier Proteins Human genes 0.000 title abstract 2
- 108010078791 Carrier Proteins Proteins 0.000 title abstract 2
- 239000013604 expression vector Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 238000004113 cell culture Methods 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 241000238631 Hexapoda Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 108010076363 licheninase Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 210000001938 protoplast Anatomy 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000011084 recovery Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
- C12N9/2448—Licheninase (3.2.1.73)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1278—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Bacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01073—Licheninase (3.2.1.73)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47249503P | 2003-05-22 | 2003-05-22 | |
PCT/US2004/016452 WO2005026375A2 (en) | 2003-05-22 | 2004-05-24 | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0410562A BRPI0410562A (pt) | 2006-06-20 |
BRPI0410562B1 BRPI0410562B1 (pt) | 2019-09-03 |
BRPI0410562B8 true BRPI0410562B8 (pt) | 2021-05-25 |
Family
ID=34312145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0410562A BRPI0410562B8 (pt) | 2003-05-22 | 2004-05-24 | proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira |
Country Status (8)
Country | Link |
---|---|
US (4) | US20060265787A1 (pt) |
EP (1) | EP1664322B1 (pt) |
CN (2) | CN1833030B (pt) |
AU (2) | AU2004272972A1 (pt) |
BR (1) | BRPI0410562B8 (pt) |
CA (1) | CA2526720C (pt) |
ES (1) | ES2427641T3 (pt) |
WO (1) | WO2005026375A2 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8148608B2 (en) * | 2004-02-20 | 2012-04-03 | Fraunhofer Usa, Inc | Systems and methods for clonal expression in plants |
US7683238B2 (en) * | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
US7692063B2 (en) * | 2002-11-12 | 2010-04-06 | Ibio, Inc. | Production of foreign nucleic acids and polypeptides in sprout systems |
ES2531125T3 (es) | 2003-02-03 | 2015-03-10 | Ibio Inc | Sistema para la expresión de genes en plantas |
WO2005026375A2 (en) | 2003-05-22 | 2005-03-24 | Fraunhofer Usa, Inc. | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
KR101446025B1 (ko) | 2005-08-03 | 2014-10-01 | 아이바이오, 인크. | 면역글로불린의 생산을 위한 조성물 및 방법 |
WO2007095304A2 (en) * | 2006-02-13 | 2007-08-23 | Fraunhofer Usa, Inc. | Production of foreign nucleic acids and polypeptides in plant systems |
US8277816B2 (en) * | 2006-02-13 | 2012-10-02 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
BRPI0707733B1 (pt) * | 2006-02-13 | 2019-12-31 | Fraunhofer Usa Inc | antígeno isolado, composição de vacina, uso da referida composição e método para produção de uma proteína de antígeno |
AU2007215082B2 (en) * | 2006-02-13 | 2012-07-12 | Ibio, Inc. | HPV antigens, vaccine compositions, and related methods |
BRPI0810865A2 (pt) * | 2007-04-28 | 2017-05-09 | Fraunhofer Usa Inc | antígenos de tripanossoma, composições vacinais, e métodos relacionados |
CA2692933C (en) | 2007-07-11 | 2016-10-18 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
BRPI0815662A2 (pt) * | 2007-08-20 | 2016-09-27 | Fraunhofer Usa Inc | vacinas, antígenos, composições, e métodos profilácticos e terapêuticos para gripe |
BRPI0919485A2 (pt) * | 2008-09-28 | 2015-12-01 | Fraunhofer Usa Inc | vacinas, antígenos, composições de plasmodium e métodos |
US8734803B2 (en) | 2008-09-28 | 2014-05-27 | Ibio Inc. | Humanized neuraminidase antibody and methods of use thereof |
CA2776144C (en) | 2009-09-29 | 2020-10-27 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
US9913890B2 (en) | 2012-06-22 | 2018-03-13 | Pharma Green Llc | Methods and compositions for emergency post-infection treatment of anthrax |
KR20210032400A (ko) | 2018-06-29 | 2021-03-24 | 지이 뉴트리언츠, 인크. | 아게라툼 spp.로부터의 추출물을 사용하여 양성 전립선 비대증(bph) 및 관련된 노화 증상을 개선하고 관리하기 위한 약초 추출물 조성물 및 방법 |
US20210283243A1 (en) * | 2020-03-11 | 2021-09-16 | Ibio, Inc. | Lichenase-covid-19 based vaccine |
Family Cites Families (118)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4196265A (en) | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
US4270537A (en) | 1979-11-19 | 1981-06-02 | Romaine Richard A | Automatic hypodermic syringe |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
JPS61134325A (ja) | 1984-12-04 | 1986-06-21 | Teijin Ltd | ハイブリツド抗体遺伝子の発現方法 |
JPS61176721A (ja) | 1985-01-31 | 1986-08-08 | Mochizuki Motor Kk | マンホ−ル蓋の開閉運搬装置 |
US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
US5618920A (en) | 1985-11-01 | 1997-04-08 | Xoma Corporation | Modular assembly of antibody genes, antibodies prepared thereby and use |
CA1283827C (en) | 1986-12-18 | 1991-05-07 | Giorgio Cirelli | Appliance for injection of liquid formulations |
GB8704027D0 (en) | 1987-02-20 | 1987-03-25 | Owen Mumford Ltd | Syringe needle combination |
US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
US4940460A (en) | 1987-06-19 | 1990-07-10 | Bioject, Inc. | Patient-fillable and non-invasive hypodermic injection device assembly |
US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
US5316931A (en) | 1988-02-26 | 1994-05-31 | Biosource Genetics Corp. | Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes |
US5977438A (en) | 1988-02-26 | 1999-11-02 | Biosource Technologies, Inc. | Production of peptides in plants as viral coat protein fusions |
US5339163A (en) | 1988-03-16 | 1994-08-16 | Canon Kabushiki Kaisha | Automatic exposure control device using plural image plane detection areas |
US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
GB8823869D0 (en) | 1988-10-12 | 1988-11-16 | Medical Res Council | Production of antibodies |
FR2638359A1 (fr) | 1988-11-03 | 1990-05-04 | Tino Dalto | Guide de seringue avec reglage de la profondeur de penetration de l'aiguille dans la peau |
US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
DE3920358A1 (de) | 1989-06-22 | 1991-01-17 | Behringwerke Ag | Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung |
US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
US5427908A (en) | 1990-05-01 | 1995-06-27 | Affymax Technologies N.V. | Recombinant library screening methods |
US5190521A (en) | 1990-08-22 | 1993-03-02 | Tecnol Medical Products, Inc. | Apparatus and method for raising a skin wheal and anesthetizing skin |
US5661016A (en) | 1990-08-29 | 1997-08-26 | Genpharm International Inc. | Transgenic non-human animals capable of producing heterologous antibodies of various isotypes |
US5625126A (en) | 1990-08-29 | 1997-04-29 | Genpharm International, Inc. | Transgenic non-human animals for producing heterologous antibodies |
US5770429A (en) | 1990-08-29 | 1998-06-23 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
US5633425A (en) | 1990-08-29 | 1997-05-27 | Genpharm International, Inc. | Transgenic non-human animals capable of producing heterologous antibodies |
US5545806A (en) | 1990-08-29 | 1996-08-13 | Genpharm International, Inc. | Ransgenic non-human animals for producing heterologous antibodies |
US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
US5527288A (en) | 1990-12-13 | 1996-06-18 | Elan Medical Technologies Limited | Intradermal drug delivery device and method for intradermal delivery of drugs |
ES2204890T3 (es) | 1991-03-06 | 2004-05-01 | Merck Patent Gmbh | Anticuerpos monoclonales humanizados. |
WO1992018619A1 (en) | 1991-04-10 | 1992-10-29 | The Scripps Research Institute | Heterodimeric receptor libraries using phagemids |
GB9118204D0 (en) | 1991-08-23 | 1991-10-09 | Weston Terence E | Needle-less injector |
SE9102652D0 (sv) | 1991-09-13 | 1991-09-13 | Kabi Pharmacia Ab | Injection needle arrangement |
CA2078539C (en) | 1991-09-18 | 2005-08-02 | Kenya Shitara | Process for producing humanized chimera antibody |
ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
EP0617706B1 (en) | 1991-11-25 | 2001-10-17 | Enzon, Inc. | Multivalent antigen-binding proteins |
GB9125979D0 (en) | 1991-12-06 | 1992-02-05 | Wellcome Found | Antibody |
US5667988A (en) | 1992-01-27 | 1997-09-16 | The Scripps Research Institute | Methods for producing antibody libraries using universal or randomized immunoglobulin light chains |
ATE171472T1 (de) | 1992-02-19 | 1998-10-15 | Schering Corp | Klonierung und expression von humanisierten monoklonalen antikörpern gegen menschliches interleukin-4 |
US5328483A (en) | 1992-02-27 | 1994-07-12 | Jacoby Richard M | Intradermal injection device with medication and needle guard |
US6004555A (en) | 1992-03-05 | 1999-12-21 | Board Of Regents, The University Of Texas System | Methods for the specific coagulation of vasculature |
EP1306095A3 (en) | 1992-03-05 | 2003-06-25 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
US5877289A (en) | 1992-03-05 | 1999-03-02 | The Scripps Research Institute | Tissue factor compositions and ligands for the specific coagulation of vasculature |
US6093399A (en) | 1992-03-05 | 2000-07-25 | Board Of Regents, The University Of Texas System | Methods and compositions for the specific coagulation of vasculature |
US5965132A (en) | 1992-03-05 | 1999-10-12 | Board Of Regents, The University Of Texas System | Methods and compositions for targeting the vasculature of solid tumors |
US5733743A (en) | 1992-03-24 | 1998-03-31 | Cambridge Antibody Technology Limited | Methods for producing members of specific binding pairs |
US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
US5569189A (en) | 1992-09-28 | 1996-10-29 | Equidyne Systems, Inc. | hypodermic jet injector |
US5334144A (en) | 1992-10-30 | 1994-08-02 | Becton, Dickinson And Company | Single use disposable needleless injector |
US5693506A (en) | 1993-11-16 | 1997-12-02 | The Regents Of The University Of California | Process for protein production in plants |
WO1995024176A1 (en) | 1994-03-07 | 1995-09-14 | Bioject, Inc. | Ampule filling device |
US5466220A (en) | 1994-03-08 | 1995-11-14 | Bioject, Inc. | Drug vial mixing and transfer device |
EP1167379A3 (en) | 1994-07-15 | 2004-09-08 | University Of Iowa Research Foundation | Immunomodulatory oligonucleotides |
US5599302A (en) | 1995-01-09 | 1997-02-04 | Medi-Ject Corporation | Medical injection system and method, gas spring thereof and launching device using gas spring |
US5705154A (en) | 1995-03-08 | 1998-01-06 | Schering Corporation | Humanized monoclonal antibodies against human interleukin-4 |
US5702892A (en) | 1995-05-09 | 1997-12-30 | The United States Of America As Represented By The Department Of Health And Human Services | Phage-display of immunoglobulin heavy chain libraries |
US5730723A (en) | 1995-10-10 | 1998-03-24 | Visionary Medical Products Corporation, Inc. | Gas pressured needle-less injection device and method |
US5893397A (en) | 1996-01-12 | 1999-04-13 | Bioject Inc. | Medication vial/syringe liquid-transfer apparatus |
GB9607549D0 (en) | 1996-04-11 | 1996-06-12 | Weston Medical Ltd | Spring-powered dispensing device |
US6042832A (en) | 1996-08-28 | 2000-03-28 | Thomas Jefferson University | Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins |
US6103511A (en) * | 1996-10-04 | 2000-08-15 | University Of Georgia Research Foundation, Inc. | Lichenase and coding sequences |
AU721534B2 (en) * | 1996-10-04 | 2000-07-06 | University Of Georgia Research Foundation, Inc., The | Fungal lichenase and coding sequences |
SI1325932T1 (pt) | 1997-04-07 | 2005-08-31 | Genentech Inc | |
US5993412A (en) | 1997-05-19 | 1999-11-30 | Bioject, Inc. | Injection apparatus |
IL134341A0 (en) | 1997-08-05 | 2001-04-30 | Stressgen Biotechnologies Corp | Compositions for inducing an immune response containing an hpv protein antigen |
US6037456A (en) | 1998-03-10 | 2000-03-14 | Biosource Technologies, Inc. | Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
IL141312A0 (en) | 1998-08-11 | 2002-03-10 | Biosource Tech Inc | Method for recovering proteins from the interstitial fluid of plant tissues |
WO2000020612A2 (en) | 1998-10-07 | 2000-04-13 | Syngenta Participations Ag | Therapeutically active proteins in plants |
WO2000025574A1 (en) | 1998-10-30 | 2000-05-11 | Thomas Jefferson University | Production of biomedical peptides and proteins in plants using plant virus vectors |
JP2003517280A (ja) | 1999-02-05 | 2003-05-27 | トーマス・ジェファーソン・ユニバーシティ | トランス相補性システムを用いての植物における生物医学用ペプチド及びタンパク質の生成 |
US6734173B1 (en) | 1999-10-20 | 2004-05-11 | Johns Hopkins University | HSP DNA vaccines |
WO2001070663A2 (en) | 2000-03-17 | 2001-09-27 | Corixa Corporation | Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors |
ATE376059T1 (de) | 2000-06-23 | 2007-11-15 | Wyeth Corp | Assemblierung von wildtyp und chimären influenzavirus-ähnlichen partikeln (vlps) |
IL153474A0 (en) | 2000-06-26 | 2003-07-06 | Stressgen Biotechnologies Corp | Human papilloma virus treatment |
WO2002000892A1 (en) | 2000-06-26 | 2002-01-03 | Glaxosmithkline Biologicals S.A. | Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest |
JP5087201B2 (ja) | 2000-08-03 | 2012-12-05 | ジョンズ・ホプキンス・ユニバーシティ | 抗原に小胞体シャペロンポリペプチドを連結した分子ワクチン |
UA80809C2 (en) | 2001-11-05 | 2007-11-12 | Process for preparation of protective antigen protein of anthracis with e.coli | |
EP1456390B1 (en) | 2001-12-26 | 2011-03-02 | University Of Central Florida | Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
US20040170606A1 (en) | 2002-06-07 | 2004-09-02 | Palmer Kenneth E. | Production of peptides in plants as viral coat protein fusions |
US7683238B2 (en) | 2002-11-12 | 2010-03-23 | iBio, Inc. and Fraunhofer USA, Inc. | Production of pharmaceutically active proteins in sprouted seedlings |
US8148608B2 (en) | 2004-02-20 | 2012-04-03 | Fraunhofer Usa, Inc | Systems and methods for clonal expression in plants |
ES2531125T3 (es) | 2003-02-03 | 2015-03-10 | Ibio Inc | Sistema para la expresión de genes en plantas |
AU2004235800B2 (en) | 2003-05-05 | 2010-02-18 | Dow Agrosciences Llc | Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production |
BRPI0410340A (pt) | 2003-05-05 | 2006-05-30 | Dow Agrosciences Llc | vetores e células para preparar composições imunoprotetoras derivadas de plantas transgênicas |
WO2005026375A2 (en) | 2003-05-22 | 2005-03-24 | Fraunhofer Usa, Inc. | Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
EP1633312A4 (en) | 2003-06-16 | 2012-09-26 | Medimmune Llc | INFLUENZA HEMAGGLUTININE AND NEURAMINIDASE VARIANTS |
CZ297389B6 (cs) | 2003-07-03 | 2006-11-15 | Ústav Molekulární Biologie Rostlin Av Cr | Fúzní protein pro vakcinaci proti lidskému papillomaviru a zpusob jeho produkce |
DK1682667T3 (da) | 2003-11-10 | 2010-08-23 | Icon Genetics Gmbh | RNA-virus afledt plantekspressionssystem |
DK2177537T3 (da) | 2004-01-09 | 2011-12-12 | Pfizer | Antistoffer til MAdCAM |
ATE530196T1 (de) | 2004-03-03 | 2011-11-15 | Iq Therapeutics Bv | Menschliches anthrax-toxin neutralisierende monoklonale antikörper und verfahren zu deren anwendung |
EP1749212A2 (en) | 2004-04-23 | 2007-02-07 | The University Of Georgia Research Foundation, Inc. | Diagnostic assay for trypanosoma cruzi infection |
CA2568020C (en) | 2004-05-25 | 2015-04-07 | Medimmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
EP1616959A1 (en) | 2004-07-07 | 2006-01-18 | Icon Genetics AG | Biological safe transient protein expression in plants |
US7794731B2 (en) | 2004-12-16 | 2010-09-14 | Wake Forest University Health Sciences | Use of flagellin in the immunotherapy of Yersinia pestis |
US20090047303A1 (en) | 2005-05-16 | 2009-02-19 | Alan Shaw | Method for improving the immunogenicity of plasmodium antigens |
CA2637837A1 (en) | 2006-01-26 | 2007-08-09 | Hx Diagnostics, Inc. | Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
WO2007095304A2 (en) | 2006-02-13 | 2007-08-23 | Fraunhofer Usa, Inc. | Production of foreign nucleic acids and polypeptides in plant systems |
BRPI0707733B1 (pt) | 2006-02-13 | 2019-12-31 | Fraunhofer Usa Inc | antígeno isolado, composição de vacina, uso da referida composição e método para produção de uma proteína de antígeno |
AU2007215082B2 (en) | 2006-02-13 | 2012-07-12 | Ibio, Inc. | HPV antigens, vaccine compositions, and related methods |
US8277816B2 (en) | 2006-02-13 | 2012-10-02 | Fraunhofer Usa, Inc. | Bacillus anthracis antigens, vaccine compositions, and related methods |
EP2029167A4 (en) | 2006-06-16 | 2010-06-16 | Dow Agrosciences Llc | NEW DNA SEQUENCES, VECTORS AND PROTEINS OF BIRD FLUID HEMOGGLUTININE |
JP2010500034A (ja) | 2006-08-09 | 2010-01-07 | メッドイミューン バクシーンズ,インコーポレイティド | インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体 |
WO2008033105A1 (en) | 2006-09-13 | 2008-03-20 | Dso National Laboratories | Hemagglutinin antibody and uses thereof |
EP2061808A4 (en) | 2006-09-15 | 2009-11-18 | Fraunhofer Usa Inc | INFLUENZA ANTIBODIES, COMPOSITIONS, AND ASSOCIATED METHODS |
CN103497255B (zh) | 2006-10-16 | 2015-11-11 | 美国国有健康与人类服务部(马里兰州) | 作为疟疾疫苗的恶性疟原虫表面蛋白的偶联物 |
FR2911608B1 (fr) | 2007-01-23 | 2009-04-03 | Centre Nat Rech Scient | Nouvelles compositions vaccinales anti paludique et ses utilisations. |
US8124092B2 (en) | 2007-03-13 | 2012-02-28 | Institute For Research In Biomedicine | Antibodies against H5N1 strains of influenza A virus |
BRPI0810865A2 (pt) | 2007-04-28 | 2017-05-09 | Fraunhofer Usa Inc | antígenos de tripanossoma, composições vacinais, e métodos relacionados |
CA2692933C (en) | 2007-07-11 | 2016-10-18 | Fraunhofer Usa, Inc. | Yersinia pestis antigens, vaccine compositions, and related methods |
BRPI0815662A2 (pt) | 2007-08-20 | 2016-09-27 | Fraunhofer Usa Inc | vacinas, antígenos, composições, e métodos profilácticos e terapêuticos para gripe |
KR20090042652A (ko) | 2007-10-26 | 2009-04-30 | 주식회사 바이오노트 | 고병원성 조류 인플루엔자 바이러스 감염증을 위한 항체치료방법 |
BRPI0818268A2 (pt) | 2007-10-31 | 2017-05-09 | Univ Central Florida Res Found Inc | antígenos de vacina humana derivados de cloroplasto contra a malária |
WO2010036970A2 (en) | 2008-09-25 | 2010-04-01 | Fraunhofer Usa, Inc. | Influenza vaccines, antigens, compositions, and methods |
US8734803B2 (en) | 2008-09-28 | 2014-05-27 | Ibio Inc. | Humanized neuraminidase antibody and methods of use thereof |
-
2004
- 2004-05-24 WO PCT/US2004/016452 patent/WO2005026375A2/en active Search and Examination
- 2004-05-24 BR BRPI0410562A patent/BRPI0410562B8/pt active IP Right Grant
- 2004-05-24 ES ES04776107T patent/ES2427641T3/es not_active Expired - Lifetime
- 2004-05-24 CA CA 2526720 patent/CA2526720C/en not_active Expired - Lifetime
- 2004-05-24 CN CN200480020879.0A patent/CN1833030B/zh not_active Expired - Lifetime
- 2004-05-24 EP EP20040776107 patent/EP1664322B1/en not_active Expired - Lifetime
- 2004-05-24 CN CN201210394281.4A patent/CN103074316B/zh not_active Expired - Lifetime
- 2004-05-24 AU AU2004272972A patent/AU2004272972A1/en not_active Abandoned
- 2004-11-19 US US10/993,160 patent/US20060265787A1/en not_active Abandoned
-
2009
- 2009-11-24 US US12/625,129 patent/US8173408B2/en not_active Expired - Fee Related
-
2010
- 2010-02-23 AU AU2010200667A patent/AU2010200667B2/en not_active Expired
-
2012
- 2012-04-12 US US13/445,492 patent/US8591909B2/en not_active Expired - Lifetime
-
2013
- 2013-10-23 US US14/060,793 patent/US9012199B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ES2427641T3 (es) | 2013-10-31 |
CN103074316B (zh) | 2015-10-21 |
CN1833030B (zh) | 2014-07-23 |
EP1664322A2 (en) | 2006-06-07 |
US9012199B2 (en) | 2015-04-21 |
CN103074316A (zh) | 2013-05-01 |
AU2010200667B2 (en) | 2013-03-14 |
AU2010200667A1 (en) | 2010-03-18 |
US8173408B2 (en) | 2012-05-08 |
US8591909B2 (en) | 2013-11-26 |
CN1833030A (zh) | 2006-09-13 |
BRPI0410562B1 (pt) | 2019-09-03 |
WO2005026375A2 (en) | 2005-03-24 |
US20060265787A1 (en) | 2006-11-23 |
US20120282288A1 (en) | 2012-11-08 |
CA2526720C (en) | 2013-10-22 |
US20140141508A1 (en) | 2014-05-22 |
US20100227373A1 (en) | 2010-09-09 |
CA2526720A1 (en) | 2005-03-24 |
EP1664322B1 (en) | 2013-07-10 |
EP1664322A4 (en) | 2007-01-10 |
WO2005026375A3 (en) | 2006-03-02 |
AU2004272972A1 (en) | 2005-03-24 |
BRPI0410562A (pt) | 2006-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0410562B8 (pt) | proteína de veículo e seu método de produção em uma planta, ácido nucleico isolado, vetor de expressão e célula hospedeira | |
PE20140867A1 (es) | Axmi-115, axmi-113, axmi-005, axmi-163 y axmi-184: proteinas insecticidas y metodos para su uso | |
BRPI0814781A8 (pt) | ''proteína, sequência de ácido nucleico, método para a produção de ácido itacônico, vetor, célula hospedeira, e, uso de um ácido cis-aconítico descarboxilase'' | |
BRPI0517121A (pt) | célula hospedeira eucariótica de planta não-superior que contém proteìna de fusão recombinante dentro de conjuntos do tipo corpo de proteìna recombinante ( rpblas ), método para a produção de uma proteìna de fusão e molécula de ácido nucléico recombinante | |
CO5601037A2 (es) | Anticuerpos anti-a beta y sus usos | |
UY27864A1 (es) | Producción de péptidos y proteinas por acumulación de cuerpos proteicos derivados de retículo endoplásmico en plantas | |
HK1082761A1 (en) | Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy | |
NO20092278L (no) | Mikroorganismer som baerere av nukleotid sekvenser kodende for antigener og protein toksiner, fremgangsmate for fremstilling og anvendelser derav | |
BR122019022434B8 (pt) | método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular | |
BR9814404A (pt) | " clonagem de expressão em fungos filamentosos " | |
BR0008772B1 (pt) | vetor de expressão, célula bacteriana ou fúngica cultivada, processos para expandir in vitro células hematopoiéticas e progenitores de células hematopoiéticas, e para detectar a presença de rna de ligando zalfa11 e de ligando zalfa 11 in vitro em uma amostra biológica. | |
DE60336228D1 (de) | Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden | |
MX2007010489A (es) | Co-expresion recombinante de reductasa de epoxido de vitamina k subunidad 1 para mejorar la expresion de proteina dependiente de vitamina k. | |
WO2006039622A3 (en) | Feeding buffers, systems, and methods for in vitro synthesis of biomolecules | |
BRPI0512791A (pt) | sistema de transferência de gene biológico para células eucarióticas | |
JPWO2021100640A5 (pt) | ||
MX2019009045A (es) | Nuevas luciferasas y metodos para su uso. | |
EA201070229A1 (ru) | Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения | |
WO2003057897A3 (en) | Recombinant protein expression | |
AR043862A1 (es) | Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina | |
WO2003074706A1 (fr) | Proteine ou polypeptide ayant une activite de synthase de type substance lacrymogene, adn codant la proteine ou le polypeptide, procede d'obtention de ladite proteine ou dudit polypeptide, et molecule d'acides nucleiques inhibant la translation de l'arn messager concernant la proteine ou le peptide | |
BR112021022840A2 (pt) | Micro-organismo capaz de produzir estrictosidina aglicona, métodos para produzir estrictosidina aglicona e alcalóides indólicos monoterpênicos, construto de ácido nucleico, vetor, célula hospedeira, kit de partes, e, uso do construto, de ácido nucleico, do micro-organismo, do vetor ou da célula hospedeira | |
WO2023164003A3 (en) | Reagents for labeling biomolecules and uses thereof | |
WO2005001099A3 (en) | Protein expression system | |
US9783800B2 (en) | Method for producing peptides having azole-derived skeleton |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B15K | Others concerning applications: alteration of classification |
Free format text: AS CLASSIFICACOES ANTERIORES ERAM: C12P 21/06 , C12N 9/00 , C12N 9/24 , C12N 1/20 , C12N 15/00 , C07H 21/04 Ipc: C07K 19/00 (2006.01), C12P 21/06 (2006.01), C12N 9 |
|
B25A | Requested transfer of rights approved |
Owner name: IBIO, INC (US) |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 03/09/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/05/2004 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |